IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q2 2026 vs. Q1 2026
How the institutions holding IO Biotech, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 12 | 0 | −12 |
| Shares | 3.39M | 0 | −3.39M (−100.0%) |
| Value | $199.0K | $0 | −$199.0K (−100.0%) |
New holders (0)
Institutions that held IO Biotech, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (12)
Institutions that held IO Biotech, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Ikarian Capital, LLC | 1,386,565 | $81.4K |
| Boothbay Fund Management, LLC | 451,852 | $26.5K |
| Gsa Capital Partners LLP | 348,352 | $20.0K |
| Marshall Wace, LLP | 301,291 | $18.1K |
| XTX Topco Ltd | 265,792 | $15.6K |
| Morgan Stanley | 206,215 | $12.1K |
| Millennium Management LLC | 194,158 | $11.4K |
| Citigroup Inc | 72,495 | $4.25K |
| Jane Street Group, LLC | 57,974 | $3.40K |
| Beacon Pointe Advisors, LLC | 42,600 | $2.50K |
| Geode Capital Management, LLC | 33,307 | $1.96K |
| UBS Group AG | 30,980 | $1.83K |